Amgen (NASDAQ: AMGN) PCSK9 gets positive opinion from EMA, according to Bloomberg headlines. UPDATE - More …
Drug stocks are soaring Wednesday, after Democratic presidential candidate Hillary Clinton, who had outlined plans to to curb drug price increases was defeated by Republican Donald Trump. Morgan Stanley analysts summed up the sigh of …
In a statement, Amgen said that it appreciated hearing from investors, including Third Point, and that its management team continued to study ways to improve the company’s stock price. Executives plan to provide an update on their …
traders are definitely monitoring Bristol-Myers Squibb’s price action to see if this move attracts further buying into the stock. Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company that develops, …